Choroidal Neovascular Membrane

  • Thomas H. Williamson
Chapter

Abstract

Choroidal neovascular membranes (CNVs) most commonly occur with age-related macular degeneration (ARMD). Features of ‘dry’ AMD include hard drusen, soft drusen, ­retinal pigment epithelial disruption and geographic atrophy. Patients with extensive small drusen, non-extensive intermediate size drusen or pigment abnormalities have only a 1.3 % 5-year probability of progression to advanced AMD according to the ARED Study (Age-Related Eye Disease Study Research Group 2001). Those with extensive intermediate size drusen, at least one large druse, noncentral geographic atrophy in one or both eyes, or advanced AMD or vision loss due to AMD in one eye, are at risk of vision loss from advanced AMD in up to 50 % (large drusen with pigmentary changes) after 5 years (Ferris et al. 2005).

Keywords

Macular Hole Vitreous Haemorrhage Central Serous Chorioretinopathy Geographic Atrophy Proliferative Vitreoretinopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

macula (539,416 KB)

References

  1. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417–1436CrossRefGoogle Scholar
  2. Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R, Thumann G, Fricke J, Neugebauer A, Hilgers RD, Esser P, Walter P, Bartz-Schmidt KU (2002) Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 120(4):451–459PubMedCrossRefGoogle Scholar
  3. Angunawela RI, Williamson TH, Khan MA, Chong V (2005) Choroidal translocation with a pedicle following excision of a type 1 choroidal neovascular membrane. Br J Ophthalmol 89(3):386PubMedCrossRefGoogle Scholar
  4. Atebara NH, Thomas MA, Holekamp NM, Mandell BA, Del Priore LV (1998) Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Ophthalmology 105(9):1598–1605PubMedCrossRefGoogle Scholar
  5. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113(3):363–372PubMedCrossRefGoogle Scholar
  6. Bains HS, Patel MR, Singh H, Marcus DM (2003) Surgical treatment of extensive peripapillary choroidal neovascularization in elderly patients. Retina 23(4):469–474PubMedCrossRefGoogle Scholar
  7. bdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B (2003) One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 87(5):615–621CrossRefGoogle Scholar
  8. Berger AS, McCuen BW, Brown GC, Brownlow RL Jr (1997) Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina 17(2):94–98PubMedCrossRefGoogle Scholar
  9. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355(14):1432–1444. doi: 355/14/1432, [pii]  10.1056/NEJMoa062655 PubMedCrossRefGoogle Scholar
  10. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA (2005) Quality of life after macular translocation with 360 degrees peripheral ­retinectomy for age-related macular degeneration. Ophthalmology 112(1):144–151PubMedCrossRefGoogle Scholar
  11. Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M (2006) Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113(9):1508–1525PubMedGoogle Scholar
  12. Cooper BA, Thomas MA (2000) Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 130(2):187–191PubMedCrossRefGoogle Scholar
  13. Eckardt C, Eckardt U, Conrad HG (1999) Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237(4):313–325PubMedCrossRefGoogle Scholar
  14. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R (2005) A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 123(11):1570–1574. doi: 123/11/1570, [pii]  10.1001/archopht.123.11.1570 PubMedCrossRefGoogle Scholar
  15. Fujii GY, De Juan E, Humayun MS Jr, Chang TS (2003) Limited macular translocation for the management of subfoveal choroidal neovascularization after photodynamic therapy. Am J Ophthalmol 135(1):109–112PubMedCrossRefGoogle Scholar
  16. Fujikado T, Asonuma S, Ohji M, Kusaka S, Hayashi A, Ikuno Y, Kamei M, Oda K, Tano Y (2002) Reading ability after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol 134(6):849–856PubMedCrossRefGoogle Scholar
  17. Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S (2007) Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection. Retina 27 (3):329–334. doi:  10.1097/01.iae.0000231544.43093.40  00006982-200703000-00008 [pii]Google Scholar
  18. Gross JG, King LP, De Juan E Jr, Powers T (1996) Subfoveal neovascular membrane removal in patients with traumatic choroidal rupture. Ophthalmology 103(4):579–585PubMedGoogle Scholar
  19. Grossniklaus HE, Wilson DJ, Bressler SB, Bressler NM, Toth CA, Green WR, Miskala P (2006) Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST report no. 16. Am J Ophthalmol 141(1):93–104. doi: S0002-9394(05)00878-0, [pii]  10.1016/j.ajo.2005.07.076 PubMedCrossRefGoogle Scholar
  20. Hawkins BS, Miskala PH, Bass EB, Bressler NM, Childs AL, Mangione CM, Marsh MJ (2004) Surgical removal vs. observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST report no. 10. Arch Ophthalmol 122(11):1616–1628PubMedCrossRefGoogle Scholar
  21. Hesse L, Meitinger D, Schmidt J (1996) Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration. Ger J Ophthalmol 5(6):479–483PubMedGoogle Scholar
  22. Ichibe M, Yoshizawa T, Funaki S, Funaki H, Ozawa Y, Tanaka Y, Abe H (2002) Severe hypotony after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol 134(1):139–141PubMedCrossRefGoogle Scholar
  23. Joussen AM, Heussen FM, Joeres S, Llacer H, Prinz B, Rohrschneider K, Maaijwee KJ, van Meurs J, Kirchhof B (2006) Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 142(1):17–30PubMedCrossRefGoogle Scholar
  24. Khurana RN, Fujii GY, Walsh AC, Humayun MS, De Juan E Jr, Sadda SR (2005) Rapid recurrence of geographic atrophy after full macular translocation for nonexudative age-related macular degeneration. Ophthalmology 112(9):1586–1591PubMedCrossRefGoogle Scholar
  25. Kuhli-Hattenbach C, Fischer IB, Schalnus R, Hattenbach LO (2010) Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy. Am J Ophthalmol 149(2):316–321.e3311. doi: S0002-9394(09)00659-X, [pii]  10.1016/j.ajo.2009.08.033 PubMedCrossRefGoogle Scholar
  26. Lai JC, Lapolice DJ, Stinnett SS, Meyer CH, Arieu LM, Keller MA, Toth CA (2002) Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch Ophthalmol 120(10):1317–1324PubMedCrossRefGoogle Scholar
  27. Lappas A, Foerster AM, Weinberger AW, Coburger S, Schrage NF, Kirchhof B (2004) Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol 242(8):638–647PubMedCrossRefGoogle Scholar
  28. Lit ES, Kim RY, Damico DJ (2001) Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a consecutive series in younger patients. Retina 21(4):317–323PubMedCrossRefGoogle Scholar
  29. Machemer R, Steinhorst UH (1993a) Retinal separation, retinotomy, and macular relocation: I. Experimental studies in the rabbit eye. Graefes Arch Clin Exp Ophthalmol 231(11):629–634PubMedCrossRefGoogle Scholar
  30. Machemer R, Steinhorst UH (1993b) Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol 231(11):635–641PubMedCrossRefGoogle Scholar
  31. Melberg NS, Thomas MA, Dickinson JD, Valluri S (1996) Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 103(7):1064–1067PubMedGoogle Scholar
  32. Mruthyunjaya P, Stinnett SS, Toth CA (2004) Change in visual function after macular translocation with 360 degrees retinectomy for ­neovascular age-related macular degeneration. Ophthalmology 111(9):1715–1724PubMedCrossRefGoogle Scholar
  33. Ng EW, Bressler NM, Boyer DS, De Juan E Jr (2002) Iatrogenic choroidal neovascularization occurring in patients undergoing macular surgery. Retina 22(6):711–718PubMedCrossRefGoogle Scholar
  34. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y (1998) Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 116(10):1326–1332PubMedCrossRefGoogle Scholar
  35. Orth DH, Flood TP (1982) Management of breakthrough vitreous hemorrhage from presumed extramacular subretinal neovascularization. Retina 2(2):89–93PubMedCrossRefGoogle Scholar
  36. Oshima Y, Ohji M, Tano Y (2007) Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage. Br J Ophthalmol 91(2):193–198. doi: bjo.2006.101444, [pii]  10.1136/bjo.2006.101444 PubMedCrossRefGoogle Scholar
  37. Pertile G, Claes C (2002) Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 134(4):560–565PubMedCrossRefGoogle Scholar
  38. Phillips SJ, Sadda SR, Tso MO, Humayan MS, De Juan E Jr, Binder S (2003) Autologous transplantation of retinal pigment epithelium after mechanical debridement of Bruch’s membrane. Curr Eye Res 26(2):81–88PubMedCrossRefGoogle Scholar
  39. Pieramici DJ, De Juan E Jr, Fujii GY, Reynolds SM, Melia M, Humayun MS, Schachat AP, Hartranft CD (2000) Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 130(4):419–428PubMedCrossRefGoogle Scholar
  40. Robison CD, Krebs I, Binder S, Barbazetto IA, Kotsolis AI, Yannuzzi LA, Sadun AA, Sebag J (2009) Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol 148(1):79–82.e72. doi: S0002-9394(09)00064-6, [pii]  10.1016/j.ajo.2009.01.014 PubMedCrossRefGoogle Scholar
  41. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006a) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431. doi: 355/14/1419, [pii]  10.1056/NEJMoa054481 PubMedCrossRefGoogle Scholar
  42. Rosenfeld PJ, Rich RM, Lalwani GA (2006b) Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 19(3):361–372PubMedGoogle Scholar
  43. Ruiz-Moreno JM, de la Vega C (2001) Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients. Br J Ophthalmol 85(9):1041–1043PubMedCrossRefGoogle Scholar
  44. Singh RP, Patel C, Sears JE (2006) Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Br J Ophthalmol 90(4):429–431. doi: 90/4/429, [pii]  10.1136/bjo.2005.085001 PubMedCrossRefGoogle Scholar
  45. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird AC, Aylward GW (2002) Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology 109(8):1492–1498PubMedCrossRefGoogle Scholar
  46. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA (1992) Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99(6):952–968PubMedGoogle Scholar
  47. Uemura A, Thomas MA (2000a) Subretinal surgery for choroidal neovascularization in patients with high myopia. Arch Ophthalmol 118(3):344–350PubMedCrossRefGoogle Scholar
  48. Uemura A, Thomas MA (2000b) Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol 118(10):1373–1378PubMedCrossRefGoogle Scholar
  49. van Meurs JC, ter Averst E, Hofland LJ, van Hagen PM, Mooy CM, Baarsma GS, Kuijpers RW, Boks T, Stalmans P (2004) Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol 88(1):110–113PubMedCrossRefGoogle Scholar
  50. Wong D, Stanga P, Briggs M, Lenfestey P, Lancaster E, Li KK, Lim KS, Groenewald C (2004) Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol 88(2):186–190PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Thomas H. Williamson
    • 1
  1. 1.Department of OphthalmologySt. Thomas’ HospitalLondonUK

Personalised recommendations